Material Detail

The research paper identifies the lessons learned from the use of phage therapy as a complementary tool for individuals who requested the treatment. 260 total requests were made from April 2013 to April 2018, with only 15 patients receiving phage therapy. The outcome alongside the requests was utilized to improve the overall capacity for the therapy at QAMH. The introduction gives a reason why the clinical trial proceeded and the information they had about phage therapy before the test. Figure 1: patient care workflow depicts the screening of the individuals who requested the treatment. Demographics of the individuals were also mentioned and depicted in Table 1 while the request for the therapy is shown in Figure 2: a pie chart. The following section reveals the infection types and bacterial pathogens, also shown in Table 1. Figure 3 depicts the relative prevalence of the reported bacterial pathogens in a pie chart while Figure 4 views the proportion of the 3 most prevalent types of bacteria: E. coli, P. aeruginosa, and S. aureus, in different infection types(e.g. UTI ENT, LRTI). Figure 5 highlights the proportion of the drug-resistant strains of the three most prevalent bacterial pathogens. The patient workflow criteria were listed: (1)infection with the three bacterial pathogens which QAMH possessed potent phages against; (2)bacterial infection associated with antibiotic treatment failure; and (3) absence of other therapeutic options. The process of the phage treatment alongside other antimicrobial agents(e.g. antibiotics) is detailed with the implications for future activities in the following paragraphs to reveal the changes they would have made to produce higher, more effective results.

This will delete the comment from the database. This operation is not reversible. Are you sure you want to do it?

Thank you for reporting a broken "Go to Material" link in MERLOT to help us maintain a collection of valuable learning materials.

If you feel this material is inappropriate for the MERLOT Collection, please click SEND REPORT, and the MERLOT Team will investigate. Thank you!

You are being taken to the material on another site. This will open a new window.

Do not show me this again